Navigation Links
Frost & Sullivan Award Acknowledges Novelda's Cutting-Edge Product Innovation

OSLO, Norway, April 29, 2011 /PRNewswire/ -- The 2011 Frost & Sullivan Europe New Product Innovation Award in Radar Sensors is presented to Novelda AS (Novelda) for its state-of-the-art, high precision Novelda Impulse Radar transceiver - NVA6000.

"The Novelda NVA6000 Impulse Radar transceiver is a cutting-edge radar transceiver that incorporates extremely high frame rate and accuracy, in addition to unique penetration capabilities," remarks Frost & Sullivan Research Analyst V. Sankaranarayanan. "Integrated on a single chip, this radar transceiver transmits pulses of high bandwidth."

Based on the Continuous Time Binary Valued (CTBV) design platform, this CMOS impulse radar transceiver successfully eliminates bottlenecks prevalent in conventional digital design-based processors. Unlike traditional processors, the NVA6000 Novelda Impulse Radar sensor does not involve the use of synchronous clock-based digital designs. This enables significantly lower power consumption, while accelerating the processing speed.

"The clock-less CTBV design saves the entire energy that is otherwise used for clock driving or distribution," explains Sankaranarayanan. "In comparison, synchronous clock-based traditional digital technology consumes almost 50 per cent of the total power, as noted in the case of several conventional high-end processors."

In comparison to traditional technology, the Novelda NVA6000 Impulse Radar transceiver offers several improvements and value added features. It effectively uses even extremely short microwave pulses, which makes it ideal for high-resolution ranging.

Its exceptionally short pulse time enables very high accuracy distance tracking and even detection of static objects. Its high sensitivity enables it to detect very weak signals, even amidst considerable noise.

"In addition, as it is integrated on a single chip, the Novelda Impulse Radar transceiver can be seamlessly integrated into small mobile devices," adds Sankaranarayanan. "The ability to detect objects behind obstacles, coupled with increased speed and high sensitivity, not only makes it complementary and/or a substitute for existing technologies such as ultrasound, video and infrared sensors, but enables it to cater to new areas of application as well."

The Novelda Impulse Radar transceiver successfully caters to sensor applications across a range of sectors including health monitoring (including stress and pulse monitoring), medical diagnosis (including heart beat monitoring and 3D RF-imaging), automotive and industrial (including distance and road obstacle detection), security surveillance (such as motion detection), and energy automation and defense.

"Unlike technologies that demand free visibility, Novelda NVA6000 Impulse Radar transceiver's ability to detect objects behind obstacles, eliminates the need to clean lenses, thus ensuring cost savings for customers," concludes Sankaranarayanan. "In addition, Novelda saves costs and time for developers by supplying development kits and software, and providing development support for the entire range of available chips."

The New Product Innovation Award is presented to the company that has excelled in the following criteria: innovative element of the product, leverage leading-edge technologies in product, value-added features/benefits, increased customer ROI and customer acquisition/penetration potential.

Frost & Sullivan Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research in order to identify best practices in the industry.


Founded in 2004 and based in Norway, Novelda is a fabless semiconductor company. As an offshoot of the highly acclaimed University of Oslo, the company boasts of extremely strong research and development (R&D) and technological skills, and continues to leverage R&D partnerships formed with the university. For more information on the company, please visit


Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best-practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages 50 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 40 offices on six continents. To join our Growth Partnership, please visit


Emily Bailey | Promotions Coordinator | Best Practices | Frost & Sullivan | P: +44 (0)20 7915 7869 | F: +44 (0)20 7730 3343 |

Aage Kalsaeg, CMO, Novelda AS, aage(at)

High-resolution images:

NVA 620 Development Kit with Sinuous Antennas

NVA 6000 and NVA 6100 Impulse Radar Transceiver

This press release was issued through eReleases(R).  For more information, visit eReleases Press Release Distribution at

Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Vascular Biogenics Ltd. Presented With the Frost & Sullivan 2008 European Gene Expression Targeting Platform Technology Innovation Award
2. Frost & Sullivan Recognizes Kionixs Dominance in the MEMS Accelerometers Market Through Product Line Strategy
3. ESA Receives 2008 Frost & Sullivan North American Technology Innovation Award for Development of Integrated Metabolomics Systems
4. Celsis Receives Frost & Sullivan 2008 Best Practices Award
5. Small Animal Imaging Market: Biospace Lab Wins Frost & Sullivan Accolade for Its Successful Product Line Strategy
6. Frost & Sullivan Acknowledges ISTO Technologies Role in Developing Advanced Biologic Products for Bone Healing
7. Innovation and Strong Therapeutic Potential Seen in Adult Stem Cells, According to Frost & Sullivan
8. Frost & Sullivan Awards Genpathway 2008 Healthcare Innovation Award
9. Aposense Receives Frost & Sullivan Technology Innovation of the Year Award
10. Frost & Sullivan Presents CorMatrix Cardiovascular Inc. with 2008 Healthcare Innovation Award for the Treatment of Cardiovascular Disease
11. Frost & Sullivan Awards Baxters BioPharma Solutions Business the 2008 North American Customer Service Leadership of the Year Award
Post Your Comments:
(Date:12/1/2015)... 2015 Cepheid (Nasdaq: CPHD ) today ... Piper Jaffray Healthcare Conference in New York ... reaffirming its outlook for the fourth quarter of 2015 ... discussing longer term business model expectations. John ... continue to be the fastest growing company of the ...
(Date:12/1/2015)... 1, 2015 ... "2016 U.K. Virology and Bacteriology Testing Market: ... Tests, Supplier Shares by Test, Innovative Technologies, ... offering.  --> ) has ... Virology and Bacteriology Testing Market: Sales and ...
(Date:11/30/2015)... ... ... Global Stem Cells Group announced the opening of a new core patient care ... in northern Chile. The facilities are part of GSCG’s expansion efforts in Latin America. ... stem cell medicine to patients from around the world. , The clinics will be headed ...
(Date:11/30/2015)... 30, 2015  Culprits beware, a University at ... Jan Halámek, is taking crime scene fingerprint identification ...   -->   --> ... --> --> Halámek and ... a straightforward concept for identifying whether a culprit ...
Breaking Biology Technology:
(Date:11/12/2015)... golden retriever that stayed healthy despite having the gene ... new lead for treating this muscle-wasting disorder, report scientists ... and Harvard and the University of São Paolo in ... pinpoints a protective gene that boosts muscle regeneration, ... Children,s lab of Lou Kunkel , PhD, is ...
(Date:11/10/2015)... Nov. 10, 2015  In this report, ... basis of product, type, application, disease indication, ... this report are consumables, services, software. The ... safety biomarkers, efficacy biomarkers, and validation biomarkers. ... are diagnostics development, drug discovery and development, ...
(Date:11/4/2015)... 2015 --> ... by Transparency Market Research "Home Security Solutions Market - Global ... - 2022", the global home security solutions market is expected to ... The market is estimated to expand at a CAGR ... 2022. Rising security needs among customers at homes, the ...
Breaking Biology News(10 mins):